metformin has been researched along with Multiple Chronic Conditions in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Multiple Chronic Conditions: Two or more concurrent chronic physical, mental, or behavioral health problems in an individual.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, WL | 1 |
Aschmann, HE | 1 |
Puhan, MA | 1 |
Robbins, CW | 1 |
Bayliss, EA | 1 |
Wilson, R | 1 |
Mularski, RA | 1 |
Chan, WV | 1 |
Leff, B | 1 |
Sheehan, O | 1 |
Glover, C | 1 |
Maslow, K | 1 |
Armacost, K | 1 |
Mintz, S | 1 |
Boyd, CM | 1 |
1 other study available for metformin and Multiple Chronic Conditions
Article | Year |
---|---|
A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypog | 2019 |